Ergomed Acquires Ashfield Pharmacovigilance Inc.

Article

Applied Clinical Trials

Ergomed plc has announced the acquisition of Ashfield Pharmacovigilance Inc. from UDG Healthcare US Holdings, Inc. Ergomed has acquired the entire issued share capital of Ashfield PV for a total cash consideration of $10 million. 

For more information, click here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.